Abstract Rationale Kappa-opioid receptor (KOR) agonists are antinociceptive but have side effects that limit their therapeutic utility. New KOR agonists have been developed that are fully efficacious at the KOR but may produce fewer or reduced side effects that are typical of KOR agonists. Objectives We determined behavioral profiles for typical and atypical...
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου